{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:12:36Z","timestamp":1784257956308,"version":"3.55.0"},"reference-count":64,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AO"],"abstract":"<jats:p>Background and purpose: Low-dose CT screening of high-risk groups has been shown to reduce lung cancer mortality, and the European Council has therefore recommended that member states explore the feasibility and effectiveness of this approach. In this study, we evaluate the implementation of low-dose CT screening for lung cancer in a Swedish female population.\nPatient\/material and methods: Women aged 54\u201374 years in the Southern Stockholm region were contacted via an electronic questionnaire. Individuals who met the same eligibility criteria as in the NELSON trial (a minimum smoking history of 15 pack-years) were invited. The screening consisted of a baseline low-dose computed tomography (LDCT) scan, with the option for a follow-up scan in cases with intermediate findings. Findings were managed in accordance with modified Fleischner Society guidelines.\nResults: Between September 2022 and September 2024, 34,580 invitation letters were sent to randomly selected women aged 54\u201374 years 11,607 individuals (33.4%) completed the questionnaire, whereof 1,106 (10%) met the inclusion criteria. 990 (90%) individuals accepted the invitation and underwent a baseline low-dose CT scan. There were 152 intermediate and 55 positive scans at baseline, and additional eight positive scans at follow-up. Fifteen cases of Lung cancer were found, yielding a positive prediction value (PPV) of 24%. 87% of the lung cancers were in stage IA.\nInterpretation: Organized lung cancer screening in a Swedish female population proved feasible, demonstrating a good participation rate, and a cancer detection rate consistent with findings from other major screening trials.<\/jats:p>","DOI":"10.2340\/1651-226x.2026.44826","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T05:59:05Z","timestamp":1771999145000},"page":"164-172","source":"Crossref","is-referenced-by-count":4,"title":["The Stockholm Pilot study for Lung cancer Screening (Stockholm PLUS): feasibility of baseline low-dose CT lung cancer screening in a high-risk Swedish female population"],"prefix":"10.2340","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9405-9844","authenticated-orcid":false,"given":"Oscar","family":"Grundberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5285-2200","authenticated-orcid":false,"given":"Paulina","family":"Kalinowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1821-6217","authenticated-orcid":false,"given":"Pierre","family":"Hillegren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8839-4919","authenticated-orcid":false,"given":"Nicolas","family":"Peyrard Janvid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6748-5140","authenticated-orcid":false,"given":"Axel","family":"Dimberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Markholm Nordgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3910-7086","authenticated-orcid":false,"given":"Fredrik","family":"Strand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4630-2832","authenticated-orcid":false,"given":"Vitali","family":"Grozman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Wagenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"142746","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3): 209\u2013249.","DOI":"10.3322\/caac.21660"},{"key":"142747","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3322\/caac.21660","DOI":"10.3322\/caac.21660"},{"key":"142748","doi-asserted-by":"crossref","unstructured":"de Groot P, Munden RF. Lung cancer epidemiology, risk factors, and prevention. Radiol Clin North Am. 2012;50: 863\u2013876.","DOI":"10.1016\/j.rcl.2012.06.006"},{"key":"142749","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.rcl.2012.06.006","DOI":"10.1016\/j.rcl.2012.06.006"},{"key":"142750","doi-asserted-by":"crossref","unstructured":"Malhotra J, Malvezzi M, Negri E, La Vecchia C, Boffetta P. Risk \u00adfactors for lung cancer worldwide. Eur Respir J. 2016;48(3): 889\u2013902.","DOI":"10.1183\/13993003.00359-2016"},{"key":"142751","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1183\/13993003.00359-2016","DOI":"10.1183\/13993003.00359-2016"},{"key":"142752","doi-asserted-by":"crossref","unstructured":"Remon J, Soria JC, Peters S. Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy. Ann Oncol. 2021;32:1637\u20131642.","DOI":"10.1016\/j.annonc.2021.08.1994"},{"key":"142753","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.annonc.2021.08.1994","DOI":"10.1016\/j.annonc.2021.08.1994"},{"key":"142754","doi-asserted-by":"crossref","unstructured":"Rami-Porta R, Nishimura KK, Giroux DJ, Detterbeck F, Cardillo G, Edwards JG, et al. The International Association for the study of lung cancer lung cancer staging project: proposals for revision of the TNM Stage groups in the forthcoming (ninth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2024;19(7):1007\u20131027.","DOI":"10.1016\/j.jtho.2024.02.011"},{"key":"142755","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jtho.2024.02.011","DOI":"10.1016\/j.jtho.2024.02.011"},{"key":"142756","doi-asserted-by":"crossref","unstructured":"Adams SJ, Stone E, Baldwin DR, Vliegenthart R, Lee P, Fintelmann FJ. Lung cancer screening. Lancet. 2023;401:390\u2013408.","DOI":"10.1016\/S0140-6736(22)01694-4"},{"key":"142757","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S0140-6736(22)01694-4","DOI":"10.1016\/S0140-6736(22)01694-4"},{"key":"142758","doi-asserted-by":"crossref","unstructured":"Aberle D, Adams. A, Berg c, Black W, ClappJ, Fagerstrom R, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):390\u2013408.","DOI":"10.1056\/NEJMoa1102873"},{"key":"142759","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1056\/NEJMoa1102873","DOI":"10.1056\/NEJMoa1102873"},{"key":"142760","doi-asserted-by":"crossref","unstructured":"Horeweg N, Van Der Aalst CM, Thunnissen E, Nackaerts K, Weenink C, Groen HJM, et al. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. Am J Respir Crit Care Med. 2013;187(8):848\u2013854.","DOI":"10.1164\/rccm.201209-1651OC"},{"key":"142761","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1164\/rccm.201209-1651OC","DOI":"10.1164\/rccm.201209-1651OC"},{"key":"142762","doi-asserted-by":"crossref","unstructured":"de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382(6):503\u2013513.","DOI":"10.1056\/NEJMoa1911793"},{"key":"142763","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1056\/NEJMoa1911793","DOI":"10.1056\/NEJMoa1911793"},{"key":"142764","doi-asserted-by":"crossref","unstructured":"Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, et al. Screening for lung cancer: US preventive services task force recommendation statement. JAMA. 2021;325(10)962\u2013970.","DOI":"10.1001\/jama.2021.1117"},{"key":"142765","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/jama.2021.1117","DOI":"10.1001\/jama.2021.1117"},{"key":"142766","doi-asserted-by":"crossref","unstructured":"Moyer VA. Screening for lung cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2014;160(5):330\u2013338.","DOI":"10.7326\/M13-2771"},{"key":"142767","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.7326\/M13-2771","DOI":"10.7326\/M13-2771"},{"key":"142768","doi-asserted-by":"crossref","unstructured":"Oudkerk M, Devaraj A, Vliegenthart R, Henzler T, Prosch H, Heussel CP, et al. European position statement on lung cancer screening. Lancet Oncol. 2017;18(12):e754\u2013e766.","DOI":"10.1016\/S1470-2045(17)30861-6"},{"key":"142769","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S1470-2045(17)30861-6","DOI":"10.1016\/S1470-2045(17)30861-6"},{"key":"142770","unstructured":"Sasieni P, Baldwin D, Barnard S, Booton R, Callister M, Crosbie P et al. NHS. Targeted screening for lung cancer with low radiation dose computed tomography Standard protocol prepared for the Lung Cancer Screening Programme- Publication reference: PR1646. 2025. [cited 2024-08-02] Available from: https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2019\/02\/2502-B1646-standard-protocol-prepared-for-the-lung-cancer-screening-programme.pdf"},{"key":"142771","unstructured":"Australian Government Department of Health and Aged Care. National Lung Cancer Screening Program (2024). Australian Government Department of Health and Aged Care; 2024. Available from https:\/\/www.health.gov.au\/sites\/default\/files\/2026-01\/national-lung-cancer-screening-program-healthcare-provider-presentation.pdf"},{"key":"142772","unstructured":"Vogel-Claussen J, Blum TG, Andreas S, Bauer TT, Barkhausen J, Harth V, et al. Statement paper on the implementation of a national organized program in Germany for the early detection of lung cancer in risk populations using low-dose CT screening including management of screening findings. RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren. 2024;196(2): 134\u2013153."},{"key":"142773","doi-asserted-by":"crossref","unstructured":"Zhang Y, Chen H. Lung cancer screening: who pays? Who receives? \u2013 the Chinese perspective. Transl Lung Cancer Res. 2021;10: 2389\u20132394.","DOI":"10.21037\/tlcr.2020.03.16"},{"key":"142774","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.21037\/tlcr.2020.03.16","DOI":"10.21037\/tlcr.2020.03.16"},{"key":"142775","unstructured":"PDF european Commission. Press release European Health Union: IP\/22\/7548. Available from https:\/\/ec.europa.eu\/commission\/presscorner\/api\/files\/document\/print\/en\/ip_22_5562\/IP_22_5562_EN.pdf. Author name: Stella Kyriakides, City: Bruxelle."},{"key":"142776","doi-asserted-by":"crossref","unstructured":"Kauczor HU, von Stackelberg O, Nischwitz E, Chorostowska-Wynimko J, Hierath M, Mathonier C, et al. Strengthening lung cancer screening in Europe: fostering participation, improving outcomes, and addressing health inequalities through collaborative initiatives in the SOLACE consortium. Insights Imaging. 2024;15(1):252.","DOI":"10.1186\/s13244-024-01814-5"},{"key":"142777","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1186\/s13244-024-01814-5","DOI":"10.1186\/s13244-024-01814-5"},{"key":"142778","doi-asserted-by":"crossref","unstructured":"Pedersen JH, S\u00f8rensen JB, Saghir Z, Fl\u00f8tten \u00d8, Brustugun OT, Ashraf H, et al. Implementation of lung cancer CT screening in the Nordic countries. Acta Oncol. 2017;56: 1249\u20131257.","DOI":"10.1080\/0284186X.2017.1329592"},{"key":"142779","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/0284186X.2017.1329592","DOI":"10.1080\/0284186X.2017.1329592"},{"key":"142780","doi-asserted-by":"crossref","unstructured":"Wichmann V, Iivanainen S, Mattila L, Kokkonen VP, Jartti A, Kurtti A, et al. Lung cancer screening in Finland: a prospective randomized trial. Acta Oncol (Madr). 2025;64:769\u2013774.","DOI":"10.2340\/1651-226X.2025.43093"},{"key":"142781","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.2340\/1651-226X.2025.43093","DOI":"10.2340\/1651-226X.2025.43093"},{"key":"142782","doi-asserted-by":"crossref","unstructured":"Revel MP, Chassagnon G. Ten reasons to screen women at risk of lung cancer. Insights Imaging. 2023;14(1)176.","DOI":"10.1186\/s13244-023-01512-8"},{"key":"142783","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1186\/s13244-023-01512-8","DOI":"10.1186\/s13244-023-01512-8"},{"key":"142784","doi-asserted-by":"crossref","unstructured":"Carioli G, Malvezzi M, Bertuccio P, Boffetta P, Levi F, La Vecchia C, et al. European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer. Ann Oncol. 2021;32(4):478\u2013487.","DOI":"10.1016\/j.annonc.2021.01.006"},{"key":"142785","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.annonc.2021.01.006","DOI":"10.1016\/j.annonc.2021.01.006"},{"key":"142786","unstructured":"Fridhammar A. IHE-Rapport-2020_5_. Institutet f\u00f6r H\u00e4lso- och Sjukv\u00e5rdsekonomi; 2020. Available from https:\/\/ihe.se\/app\/uploads\/2020\/10\/IHE-Rapport-2020_5_.pdf"},{"key":"142787","doi-asserted-by":"crossref","unstructured":"Tammem\u00e4gi MC, Hormuzd AK, Hocking WG, Church TR, Caporaso N, Kvale PA, et al. Selection criteria for lung-cancer screening. N Engl J Med. 2013;368(8):728\u201336.","DOI":"10.1056\/NEJMoa1211776"},{"key":"142788","unstructured":"https:\/\/doi.org\/10"},{"key":"142789","doi-asserted-by":"crossref","unstructured":"Becker N, Motsch E, Trotter A, Heussel CP, Dienemann H, Schnabel PA, et al. Lung cancer mortality reduction by LDCT screening \u2013 results from the randomized German LUSI trial. Int J Cancer. 2020;146(6):1503\u20131513.","DOI":"10.1002\/ijc.32486"},{"key":"142790","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/ijc.32486","DOI":"10.1002\/ijc.32486"},{"key":"142791","doi-asserted-by":"crossref","unstructured":"Quaife SL, Ruparel M, Beeken RJ, McEwen A, Isitt J, Nolan G, et al. The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and \u2018hard-to-reach\u2019 patients. BMC Cancer. 2016;16(1):281.","DOI":"10.1186\/s12885-016-2316-z"},{"key":"142792","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1186\/s12885-016-2316-z","DOI":"10.1186\/s12885-016-2316-z"},{"key":"142793","doi-asserted-by":"crossref","unstructured":"Dickson JL, Hall H, Horst C, Tisi S, Verghese P, Mullin AM, et al. Uptake of invitations to a lung health check offering low-dose CT lung cancer screening among an ethnically and socioeconomically diverse population at risk of lung cancer in the UK (SUMMIT): a prospective, longitudinal cohort study. Lancet Public Health. 2023;8(2):e130\u2013e140.","DOI":"10.1016\/S2468-2667(22)00258-4"},{"key":"142794","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S2468-2667(22)00258-4","DOI":"10.1016\/S2468-2667(22)00258-4"},{"key":"142795","doi-asserted-by":"crossref","unstructured":"Crosbie PAJ, Gabe R, Simmonds I, Kennedy M, Rogerson S, Ahmed N, et al. Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk. BMJ Open. 2020;10(9):e037075.","DOI":"10.1136\/bmjopen-2020-037075"},{"key":"142796","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1136\/bmjopen-2020-037075","DOI":"10.1136\/bmjopen-2020-037075"},{"key":"142797","doi-asserted-by":"crossref","unstructured":"Field JK, Duffy SW, Baldwin DR, Brain KE, Devaraj A, Eisen T, et al. The UK lung cancer screening trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. Health Technol Assess (Rockv). 2016;20(40):1\u2013146.","DOI":"10.3310\/hta20400"},{"key":"142798","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3310\/hta20400","DOI":"10.3310\/hta20400"},{"key":"142799","unstructured":"Stenger M. Lung cancer screening in Denmark. In: Nordic Lung \u00adcancer symposium \u2013 2025. 2025. Available from https:\/\/cancerakademin.se\/evenemang\/nordic-lungcancer-symposium-2025\/"},{"key":"142800","unstructured":"Stenger M. Project Lung Cancer Screening in Southern Denmark (PLUS). [cited 2024-08-02] Available from: https:\/\/clinicaltrials.gov\/study\/NCT06537804"},{"key":"142801","doi-asserted-by":"crossref","unstructured":"Pastorino U, Rossi M, Rosato V, Marchian\u00f2 A, Sverzellati N, Morosi C, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev. 2012;21(3):308\u2013315.","DOI":"10.1097\/CEJ.0b013e328351e1b6"},{"key":"142802","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1097\/CEJ.0b013e328351e1b6","DOI":"10.1097\/CEJ.0b013e328351e1b6"},{"key":"142803","doi-asserted-by":"crossref","unstructured":"MacMahon H, Naidich DP, Goo JM, Lee KS, Leung ANC, Mayo JR, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017. Radiology. 2017;284:228\u2013243.","DOI":"10.1148\/radiol.2017161659"},{"key":"142804","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1148\/radiol.2017161659","DOI":"10.1148\/radiol.2017161659"},{"key":"142805","doi-asserted-by":"crossref","unstructured":"Baldwin DR, Callister MEJ. The British Thoracic Society guidelines on the investigation and management of pulmonary nodules. Thorax. 2015;70(8):794\u2013798.","DOI":"10.1136\/thoraxjnl-2015-207221"},{"key":"142806","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1136\/thoraxjnl-2015-207221","DOI":"10.1136\/thoraxjnl-2015-207221"},{"key":"142807","unstructured":"Henschke CI, Yip R, Shaham D, Markowitz S, Deval JC, Zulueta JJ, et al. A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP). Radiology. 2023;309(2):e231988."},{"key":"142808","doi-asserted-by":"crossref","unstructured":"El Alam R, Byrne SC, Hammer MM. Rate of benign nodule resection in a lung cancer screening program. Clin Imaging. 2023;104:109984\u2013109995.","DOI":"10.1016\/j.clinimag.2023.109984"},{"key":"142809","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.clinimag.2023.109984","DOI":"10.1016\/j.clinimag.2023.109984"}],"container-title":["Acta Oncologica"],"original-title":[],"link":[{"URL":"https:\/\/actaoncologica.se\/actaoncologica\/article\/download\/44826\/52991","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/actaoncologica.se\/actaoncologica\/article\/download\/44826\/52991","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T05:59:53Z","timestamp":1771999193000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaoncologica.se\/actaoncologica\/article\/view\/44826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":64,"URL":"https:\/\/doi.org\/10.2340\/1651-226x.2026.44826","relation":{},"ISSN":["1651-226X"],"issn-type":[{"value":"1651-226X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]}}}